Catalyst Wire Dossier Catalyst Wire Dossier

Ruboxistaurin

ruboxistaurin
Drug timelines are a Plus or Pro feature.

5 regulatory and trial events tracked for Ruboxistaurin, covering 2016-01-28 to 2017-02-01. Get the full timeline:

Most recent: Clinical Trial Update: The Effect of LY333531 on Protein in the Urine in Patients With Type 2 Diabetes [Phase 2]

See pricing